p21/Cyclin E pathway modulates anticlastogenic function of Bmi-1 in cancer cells

Int J Cancer. 2015 Mar 15;136(6):1361-70. doi: 10.1002/ijc.29114. Epub 2014 Aug 7.

Abstract

Apart from regulating stem cell self-renewal, embryonic development and proliferation, Bmi-1 has been recently reported to be critical in the maintenance of genome integrity. In searching for novel mechanisms underlying the anticlastogenic function of Bmi-1, we observed, for the first time, that Bmi-1 positively regulates p21 expression. We extended the finding that Bmi-1 deficiency induced chromosome breaks in multiple cancer cell models. Interestingly, we further demonstrated that knockdown of cyclin E or ectopic overexpression of p21 rescued Bmi-1 deficiency-induced chromosome breaks. We therefore conclude that p21/cyclin E pathway is crucial in modulating the anticlastogenic function of Bmi-1. As it is well established that the overexpression of cyclin E potently induces genome instability and p21 suppresses the function of cyclin E, the novel and important implication from our findings is that Bmi-1 plays an important role in limiting genomic instability in cylin E-overexpressing cancer cells by positive regulation of p21.

Keywords: Bmi-1; cyclin E; genomic instability; p21; replicative stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Chromosome Aberrations
  • Cyclin E / physiology*
  • Cyclin-Dependent Kinase Inhibitor p21 / physiology*
  • Genomic Instability*
  • Humans
  • Polycomb Repressive Complex 1 / physiology*
  • Signal Transduction / physiology*

Substances

  • BMI1 protein, human
  • CDKN1A protein, human
  • Cyclin E
  • Cyclin-Dependent Kinase Inhibitor p21
  • Polycomb Repressive Complex 1